Randomized Trialhigh evidence

Long-Term Survival After Initial Invasive or Conservative Management of Stable Coronary Disease in ISCHEMIA-EXTEND.

JAMA·November 7, 2026·PMID 42998244

Why it matters

For patients with stable coronary disease and moderate-to-severe ischemia, the decision between routine invasive management and initial medical therapy has been debated. This long-term follow-up provides robust evidence that an initial invasive strategy does not confer a survival advantage over a conservative approach, informing shared decision-making and guideline recommendations.

Infographic summary of Long-Term Survival After Initial Invasive or Conservative Management of Stable Coronary Disease in ISCHEMIA-EXTEND.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled